Alan P. Watt
About
Alan P. Watt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry.
According to data from OpenAlex, Alan P. Watt has authored 68 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 12 papers in Organic Chemistry. Recurrent topics in Alan P. Watt's work include Neuropeptides and Animal Physiology (13 papers), Analytical Chemistry and Chromatography (8 papers) and Inflammasome and immune disorders (8 papers). Alan P. Watt is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Analytical Chemistry and Chromatography (8 papers) and Inflammasome and immune disorders (8 papers). Alan P. Watt collaborates with scholars based in United States, United Kingdom and Switzerland. Alan P. Watt's co-authors include David C. Evans, Deborah A. Nicoll‐Griffith, Thomas A. Baillie, Karen L Locker, Denise Morrison, Angus M. MacLeod, Nigel S. Simpkins, David A. Price, Stephen R. Fletcher and Raymond Baker and has published in prestigious journals such as Nature Biotechnology, Analytical Chemistry and Analytical Biochemistry.
In The Last Decade
Alan P. Watt
66 papers receiving 2.2k citations
Hit Papers
Peers
Alan P. Watt
Paul Erhardt United States
Nicholas C. O. Tomkinson United Kingdom
Li‐Wei Zou China
Sandeep Modi United Kingdom
Shingo Nagano Japan
John C. Hackett United States
Donald Poirier Canada
Ronald E. White United States
Aaron B. Miller United States
Simon Daff United Kingdom
Citations per year, relative to Alan P. Watt Alan P. Watt (= 1×)
peers
Paul Erhardt
Countries citing papers authored by Alan P. Watt
Since
Specialization
Citations
This map shows the geographic impact of Alan P. Watt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan P. Watt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan P. Watt more than expected).
Fields of papers citing papers by Alan P. Watt
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alan P. Watt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan P. Watt. The network helps show where Alan P. Watt may publish in the future.
Co-authorship network of co-authors of Alan P. Watt
This figure shows the co-authorship network connecting the top 25 collaborators of Alan P. Watt. A scholar is included among the top collaborators of Alan P. Watt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan P. Watt. Alan P. Watt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Harrison, David, Andy Billinton, Mark G. Bock, et al.. (2025). Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an in vivo tool compound for neuroinflammatory disorders. RSC Medicinal Chemistry. 16(11). 5318–5332.
2.
Smolak, Pamela J., MyTrang Nguyen, John R. Doedens, et al.. (2024). Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances Potency. Journal of Pharmacology and Experimental Therapeutics. 388(3). 798–812.
3.
Doedens, John R., Pamela J. Smolak, MyTrang Nguyen, et al.. (2024). Pharmacological Analysis of NLRP3 Inflammasome Inhibitor Sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1H-pyrazol-4-yl)({[(2S)-oxolan-2-yl]methyl})sulfamoyl]azanide in Cellular and Mouse Models of Inflammation Provides a Translational Framework. ACS Pharmacology & Translational Science. 7(5). 1438–1456.
4.
Bignon, Alexandre, Alan P. Watt, & Michelle A. Linterman. (2017). Escherichia coli Heat-Labile Enterotoxin B Limits T Cells Activation by Promoting Immature Dendritic Cells and Enhancing Regulatory T Cell Function. Frontiers in Immunology. 8. 560–560.
5.
Pike, Andrew, Susan M. Cook, Alan P. Watt, et al.. (2007). Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands. Biopharmaceutics & Drug Disposition. 28(6). 275–282.
6.
Meneses‐Lorente, Georgina, Claire Guyomard, Christophe Chesné, et al.. (2006). Utility of Long-Term Cultured Human Hepatocytes as an in Vitro Model for Cytochrome P450 Induction. Drug Metabolism and Disposition. 35(2). 215–220.
7.
Evans, David C., Alan P. Watt, Deborah A. Nicoll‐Griffith, & Thomas A. Baillie. (2005). Drug−Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development Volume 17, Number 1, January 2004, pp 3−16. Chemical Research in Toxicology. 18(11). 1777–1777.
8.
Hop, Cornelis E. C. A., Yanfeng Wang, Sanjeev Kumar, et al.. (2002). Identification of Metabolites of a Substance P (Neurokinin 1 Receptor) Antagonist in Rat Hepatocytes and Rat Plasma. Drug Metabolism and Disposition. 30(8). 937–943.
9.
O’Connor, Desmond, et al.. (2002). Determination of drug concentrations in plasma by a highly automated, generic and flexible protein precipitation and liquid chromatography/tandem mass spectrometry method applicable to the drug discovery environment. Rapid Communications in Mass Spectrometry. 16(11). 1065–1071.
10.
Shaw, Duncan, Gary G. Chicchi, Jason Elliott, et al.. (2001). 2-Aryl indole NK1 antagonists: optimisation of the amide substituent. Bioorganic & Medicinal Chemistry Letters. 11(23). 3031–3034.
11.
Chicchi, Gary G., Jason Elliott, Gregory J. Hollingworth, et al.. (2001). 2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution. Bioorganic & Medicinal Chemistry Letters. 11(9). 1233–1236.
12.
Hitzel, Laure, Alan P. Watt, & Karen L Locker. (2000). An Increased Throughput Method for the Determination of Partition Coefficients. Pharmaceutical Research. 17(11). 1389–1395.
13.
Watt, Alan P., Laure Hitzel, Denise Morrison, & Karen L Locker. (2000). Determination of the in vitro metabolism of (+)- and (−)-epibatidine. Journal of Chromatography A. 896(1-2). 229–238.
14.
Watt, Alan P., Laure Hitzel, Denise Morrison, & Karen L Locker. (2000). Use of chiral liquid chromatography–tandem mass spectrometry to investigate the metabolism of racemic cholecystokinin-B antagonists. Journal of Chromatography A. 896(1-2). 217–227.
15.
Niel, Monique B. van, Margaret S. Beer, David C. Evans, et al.. (1999). Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1 and 5-HT re-uptake ligands. Bioorganic & Medicinal Chemistry Letters. 9(22). 3243–3248.
16.
Bristow, Linda J., Peter H. Hutson, Janusz J. Kulagowski, et al.. (1996). Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 492–501.
17.
Street, Leslie J., R. BAKER, Richard A. Jelley, et al.. (1995). Synthesis and Serotonergic Activity of N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and Analogs: Potent Agonists for 5-HT1D Receptors. Journal of Medicinal Chemistry. 38(10). 1799–1810.
18.
Showell, Graham A., Joseph G. Neduvelil, Stephen R. Fletcher, et al.. (1994). High-Affinity and Potent, Water-Soluble 5-Amino-1,4-benzodiazepine CCKB/Gastrin Receptor Antagonists Containing a Cationic Solubilizing Group. Journal of Medicinal Chemistry. 37(6). 719–721.
19.
Atack, John, Susan M. Cook, Alan P. Watt, Stephen R. Fletcher, & C I Ragan. (1993). In Vitro and In Vivo Inhibition of Inositol Monophosphatase by the Bisphosphonate L‐690,330. Journal of Neurochemistry. 60(2). 652–658.
20.
Atack, John, Susan M. Cook, Alan P. Watt, & C I Ragan. (1992). Measurement of Lithium‐Induced Changes in Mouse Inositol(1)Phosphate Levels In Vivo. Journal of Neurochemistry. 59(5). 1946–1954.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paul Erhardt Breakdown of academic impact, for papers by Nicholas C. O. Tomkinson Breakdown of academic impact, for papers by Li‐Wei Zou Breakdown of academic impact, for papers by Sandeep Modi Breakdown of academic impact, for papers by Shingo Nagano Breakdown of academic impact, for papers by John C. Hackett Breakdown of academic impact, for papers by Donald Poirier Breakdown of academic impact, for papers by Ronald E. White Breakdown of academic impact, for papers by Aaron B. Miller Breakdown of academic impact, for papers by Simon Daff